Cholinergic agonists as novel treatments for schizophrenia: the promise of rational drug development for psychiatry

Am J Psychiatry. 2008 Aug;165(8):931-6. doi: 10.1176/appi.ajp.2008.08050769.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Acetylcholine / biosynthesis
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism
  • Cholinergic Agonists / pharmacology
  • Cholinergic Agonists / therapeutic use*
  • Cognition Disorders / diagnosis
  • Cognition Disorders / etiology
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Humans
  • Interneurons / physiology
  • Neural Conduction / drug effects
  • Neurons / drug effects
  • Neurons / metabolism
  • Neuropsychological Tests
  • Psychiatry / methods*
  • Psychiatry / trends*
  • Receptors, Muscarinic / drug effects
  • Receptors, Muscarinic / metabolism
  • Receptors, Nicotinic / drug effects
  • Receptors, Nicotinic / metabolism
  • Schizophrenia / complications
  • Schizophrenia / drug therapy*

Substances

  • Cholinergic Agonists
  • Receptors, Muscarinic
  • Receptors, Nicotinic
  • Acetylcholine